Found: 7
Select item for more details and to access through your institution.
Multipotente Liganden mit kombinierter Cholinesterase- und Monoaminooxidase-Inhibition sowie Histamin-H<sub>3</sub>R-Antagonismus bei neurodegenerativen Erkrankungen.
- Published in:
- Angewandte Chemie, 2017, v. 129, n. 41, p. 12939, doi. 10.1002/ange.201706072
- By:
- Publication type:
- Article
Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H<sub>3</sub>R Antagonism for Neurodegenerative Diseases.
- Published in:
- Angewandte Chemie International Edition, 2017, v. 56, n. 41, p. 12765, doi. 10.1002/anie.201706072
- By:
- Publication type:
- Article
Acetylcholinesterase Inhibition of Diversely Functionalized Quinolinones for Alzheimer's Disease Therapy.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 11, p. 3913, doi. 10.3390/ijms21113913
- By:
- Publication type:
- Article
Automated Synthesis of New Quinoxalinetacrines.
- Published in:
- ChemistrySelect, 2020, v. 5, n. 21, p. 6491, doi. 10.1002/slct.202001593
- By:
- Publication type:
- Article
N -Hydroxy- N -Propargylamide Derivatives of Ferulic Acid: Inhibitors of Cholinesterases and Monoamine Oxidases.
- Published in:
- Molecules, 2022, v. 27, n. 21, p. 7437, doi. 10.3390/molecules27217437
- By:
- Publication type:
- Article
Synthesis of N -Substituted Pyrroles Catalyzed by Low-Cost and Commercially Available Aluminas.
- Published in:
- Catalysts (2073-4344), 2023, v. 13, n. 3, p. 603, doi. 10.3390/catal13030603
- By:
- Publication type:
- Article
Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments.
- Published in:
- Chemical Record, 2021, v. 21, n. 1, p. 162, doi. 10.1002/tcr.202000107
- By:
- Publication type:
- Article